Full-Time

Logistics Program Manager

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Compensation Overview

$100k - $130kAnnually

Mid

Sacramento, CA, USA

Position requires onsite presence in Sacramento, CA.

Category
Project Management
Operations & Logistics
Business & Strategy
Requirements
  • Bachelor’s degree required. B.S. in biology, life sciences, logistics or a related field is a plus
  • Proven experience in business process optimization
  • Experience in logistics coordination, preferably in healthcare or biomedical field
  • Understanding of regulatory requirements and guidelines related to the transportation of biological materials is preferred
  • Proficiency in using logistics management software or systems
  • Prior experience in handling cell samples or biological materials is a plus
Responsibilities
  • Schedule medical couriers to retrieve donor materials and transport those materials to Orca manufacturing sites in Sacramento
  • Schedule medical couriers to retrieve temperature controlled drug products from Orca’s Sacramento manufacturing sites and deliver to recipient transplant center locations
  • Manage flight and travel itineraries and communicate with couriers, airlines, and travel providers
  • Monitor shipment statuses to address any issues and minimize impact to internal and external parties
  • Communicate expected changes urgently and professionally to all affected parties
  • Ensure documentation and preparations required for pickups and deliveries are in place
  • Ensure post-run close out documentation is delivered in a timely manner to the QA department
  • Manage Orca’s medical courier program by: Issuing courier transport runs and assigning activities based on competency and training compliance
  • Serving on-call during courier transports to respond to non-routine issues
  • Overseeing courier invoicing and performance monitoring
  • Developing training materials and tracking courier training compliance

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to advance cell therapy treatments, addressing conditions that currently have limited effective options.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

12%

1 year growth

20%

2 year growth

42%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.

Help us improve and share your feedback! Did you find this helpful?